measles mumps and rubella vaccine live attenuated (freeze-dried) pulbere şi solvent pentru soluţie injectabilă
serum institute of india pvt.ltd - vaccin rujeolic, oreionic, rubeolic, viu atenuat - pulbere şi solvent pentru soluţie injectabilă
macropremix bovine îngrășare
s.c.guyomarc’h nutritie anamală românia- guyomarc’h, românia srl, românia - complex - pulbere orala pentru administrare in furaj - bovine
smofkabiven central fara electroliti
fresenius kabi ab - suedia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
seretide inhaler cfc free 25 µg/250 µg
glaxowellcome uk ltd. - salmeterolum+fluticasonum - susp. inhal. presurizata - 25µg/250µg - adrenergice inhalatorii adrenergice si alte med. pt. trat. bolilor obstructive c.r
seretide inhaler cfc free 25 µg/125 µg
glaxowellcome uk ltd. - salmeterolum+fluticasonum - susp. inhal. presurizata - 25µg/125µg - adrenergice inhalatorii adrenergice si alte med. pt. trat. bolilor obstructive c.r
seretide inhaler cfc free 25 µg/50 µg
glaxowellcome uk ltd. - salmeterolum+fluticasonum - susp. inhal. presurizata - 25µg/50µg - adrenergice inhalatorii adrenergice si alte med. pt. trat. bolilor obstructive c.r
imatinib actavis
actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. , efectul de imatinib pe rezultatul de transplantul de măduvă osoasă nu a fost determinată. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. experiența cu imatinib la pacienții cu mds/mpd asociate cu genei fcdp-re-aranjamente este foarte limitat. nu există studii controlate care să demonstreze un beneficiu clinic sau a crescut de supraviețuire pentru aceste boli.
ventolin 100 inhaler cfc-free
glaxowellcome uk ltd. - salbutamolum - susp. inhal. presurizata - 100µg/doza - adrenergice inhalatorii agonisti selectivi ai receptorilor beta-2 adrenergici
flixotide 125 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 125µg/doza - alte med. pt. trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi
flixotide 250 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 250µg/doza - alte med. pt.trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi